Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate

Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate


    • Product Name Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate
    • Alias Methyl 2-chloro-5-thiazolecarboxylate
    • Einecs EINECS 623-802-4
    • Mininmum Order 1 mg
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    444048

    Chemical Formula C5H4ClNO2S
    Molecular Weight 177.61
    Appearance Solid (usually)
    Color Typically white to off - white
    Odor May have a characteristic odor
    Solubility In Water Low solubility
    Solubility In Organic Solvents Soluble in some organic solvents like dichloromethane
    Stability Stable under normal conditions but may react with strong oxidizing agents

    As an accredited Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 1 kg of Methyl 2 - Chloro - 1,3 - Thiazole - 5 - Carboxylate in sealed, labeled container.
    Shipping Methyl 2 - Chloro - 1,3 - Thiazole - 5 - Carboxylate is shipped in accordance with strict chemical transport regulations. It's carefully packaged to prevent leakage, transported in suitable containers, and handled by trained personnel for safe delivery.
    Storage Methyl 2 - Chloro - 1,3 - Thiazole - 5 - Carboxylate should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Store in a tightly sealed container to prevent moisture and air exposure, which could potentially lead to decomposition or reactivity issues.
    Application of Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate
    In the kilogram-scale production of neonicotinoid insecticides targeting the nicotinic acetylcholine receptor of hemipteran pests, the synthesis route depends on Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate as a pre-functionalized heterocyclic building block that eliminates the need for late-stage lithiation of the thiazole ring. The ester is reduced to (2-chlorothiazol-5-yl)methanol using a mixed hydride system—typically sodium borohydride in the presence of zinc chloride or lithium chloride in tetrahydrofuran—at a controlled temperature range of **−5 °C** to **10 °C** in a glass-lined reactor equipped with a retreat-curve impeller agitator. A validated molar charge ratio of ester to borohydride of **1:2.3** ensures complete conversion; batch deviation exceeding **2.2** equivalents results in over-reduction byproducts that contaminate the downstream alkylation. The alcohol is then converted to 2-chloro-5-(chloromethyl)thiazole via thionyl chloride in toluene, followed by condensation with S-methyl-N-nitroisothiourea or N-methyl-N′-nitroguanidine under biphasic conditions to form clothianidin or, through a nitromethylene cycloaddition, thiamethoxam. Compliance with FAO Specification **AGP:CP/326** and certification under EU Regulation **1107/2009** Annex II requires monitoring of nitrosamine carryover to levels below **0.15 mg/kg** in the technical concentrate. The ultimate finished formulations—flowable suspension concentrates for seed treatment, water-dispersible granules for foliar application, and ultra-low-volume aerosols—must retain suspension stability as per CIPAC MT **184**. Predry the intermediate ester to a moisture content ≤ **0.5%** before charging; residual water hydrolyzes the 2-chloro substituent, generating the unreactive 2-hydroxy analogue and suppressing yield below economic viability.
    ParameterConventional BatchOptimized Continuous Flow
    Residence time (min)120–1808–12
    Yield of alcohol intermediate (%)82–8794–97
    Product purity (area%, HPLC)97.5–99.099.3–99.8
    Reactor material of constructionGlass-lined (Pfaudler)Silicon carbide microreactor

    When 2-Aminothiazole-5-Carboxylic Acid Replaces Aminobenzothiazole in Fourth-Generation Cephalosporins

    The preparation of the C-7 side chain for cefditoren pivoxil employs Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate as the electrophilic partner in a nucleophilic aromatic substitution with thiourea to install the 2-amino group. The reaction proceeds in isopropanol at **78 °C** under nitrogen, with a thiourea:ester molar charge of **1.05:1** and a catalytic charge of potassium iodide at **0.03 eq** to accelerate displacement. After saponification of the methyl ester with aqueous sodium hydroxide at **40 °C** and acidification to pH **2.8**, the isolated 2-aminothiazole-5-carboxylic acid is coupled to the cephem nucleus via an active mixed anhydride. The hydrochloride salt of the resulting intermediate is crystallized from aqueous acetone in a centrifuge-filter cascade, achieving a potassium ion residue specification of ≤ **50 ppm** to meet JP **XVIII** monograph requirements. Process solvents are controlled against ICH **Q3C(R8)** limits: acetone ≤ **5000 ppm**, isopropanol ≤ **5000 ppm**, and methyl tert-butyl ether ≤ **2500 ppm** in the final API. A critical processing boundary exists: if the pH during the acidification of the free acid drifts below **2.2**, dimeric impurity 2,2′-dithiazolyl ether forms at levels exceeding **0.10%** w/w, and the batch cannot be recovered chromatographically. The terminal dosage form is a film-coated tablet containing **200 mg** of cefditoren pivoxil, for which dissolution testing must conform to the **0.05 M** phosphate buffer method of the USP monographs without surfactant addition.

    Pre-Emergence Thiazole Herbicide Manufacturing: What Dictates Cross-Contamination Risk in Multipurpose Plants?

    Synthesis of thiazopyr herbicide begins with the condensation of Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate and 2,6-difluoroaniline in xylene under reflux with a molar ratio of **1:1.12**—the slight excess of aniline scavenges residual acid chlorides. The reaction is catalyzed by trimethylaluminum (**2 mol%**) or, in dedicated facilities, by a solid-supported Lewis acid to minimize aluminum carryover. The resulting amide intermediate is subsequently thioalkylated with isobutyl mercaptan and sodium hydride in dimethylformamide, necessitating rigorous anhydrous conditions because the 2-chloro substituent is susceptible to solvolysis above **60 °C** in moist dimethylformamide. Equipment train configuration: a Hastelloy C22 primary reactor (designed for MAWP **6 bar**) followed by a wiped-film evaporator to strip xylene to ≤ **150 ppm** before thioether formation. Compliance under US EPA **40 CFR 152** requires five-batch analysis for the chlorinated impurity profile; the di-alkylated byproduct must not exceed **0.3%** in the technical concentrate (EPA Acceptable Level of Non-Relevant Certification). A plant changeover protocol aligned with the ISPE Baseline Guide on cleaning validation is mandatory when the same reactor line is used for neonicotinoids: thiazopyr’s difluorophenyl moiety is a known sensitizer, and wipe-test acceptance criteria of ≤ **1.0 µg/100 cm²** by LC-MS/MS are enforced. Finished product forms are emulsifiable concentrates at **240 g/L** acid equivalent and granular formulations co-formulated with fertilizer carriers.Textile-industry fluorescent brighteners based on the 2,5-disubstituted thiazole chromophore often originate from this ester without an isolated intermediate, telescoping directly into a Knoevenagel condensation with cyanoacetic acid derivatives. In a typical scale-validated sequence, Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate is hydrolyzed to the free acid with hydrochloric acid (**6 N**, **2.5 vol**) and then condensed with N-methyl-2-cyanoacetamide in acetic anhydride under Dean–Stark reflux. The molar input ratio of acid to active methylene is **1:1.05**, and the temperature ramp from **110 °C** to **135 °C** must follow a slope of **2 °C/min** to avoid premature precipitation that fouls the condenser ports. Brightener performance is validated against the ISO **105-B02** xenon arc lightfastness standard and the OEKO-TEX **Standard 100** Annex 4 extractable heavy-metal limits, because the finished brilliancy additive is formulated into pad-bath liquors for polyester-cotton blends. The downstream finishing process applies a padding mangle with a wet pick-up of **70 ± 5%**, followed by a thermosol fixation at **190 °C** for **45 seconds**; any residual hydrolyzed ester that has not condensed registers as a yellowing precursor under **D65** illuminant assessment (ASTM **E313** yellowness index). The terminal article is a liquid brightener concentrate containing **25–30%** w/w active substance, dispersed in a nonionic ethoxylated alcohol vehicle.

    “Hinge-Binder” Intermediates: Chlorothiazole as a Privileged Substructure in Type II Kinase Inhibition

    In the medicinal chemistry synthesis of investigational kinase inhibitors that occupy the DFG-out allosteric pocket, Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate enables a divergent strategy wherein the chlorine atom is retained to engage the hinge region of the ATP site while the carboxylate is amidated with substituted anilines. A published route uses a three-step, one-pot protocol: ester hydrolysis with lithium hydroxide at **25 °C**, formation of an intermediate mixed carbonic anhydride with isobutyl chloroformate (**1.05 eq**) and N-methylmorpholine (**1.15 eq**), followed by coupling with 4-aminophenyl ethers at **−15 °C**. The overall yield from the ester to the isolated benzamide scaffold is **68–74%** after flash chromatography, with a critical impurity identified by LC-HRMS as the des-chloro byproduct (0.08% area). The process operates under ICH **M7(R2)** control for mutagenic impurities; purge factor calculations demonstrate that the aniline derivative’s Ames-positive alert is reduced below the **1.5 µg/day** threshold of toxicological concern when residual aniline in the final target compound is below **3 ppm**. Preclinical campaigns in a kilogram pilot plant utilize glass reaction vessels with overhead stirrers, and the addition of isobutyl chloroformate is automated via a syringe pump to maintain the exotherm below **−10 °C**. Regulatory starting material designation under ICH **Q11** is often anchored at this ester stage, making full vendor qualification questionnaires and nitrosamine risk evaluation a prerequisite for supply of GMP grade. The drug substance produced is administered as enteric-coated tablets for phase I oncology trials.
    Compliance StandardApplication DomainRelevant Clause / Test
    FAO AGP:CP/326Clothianidin Technical ConcentrateNitrosamine ≤ 0.15 mg/kg
    ICH Q3C(R8)APIs for Beta-Lactam AntibioticsResidual Solvent Classes 2 & 3
    EPA 40 CFR 152Thiazopyr Herbicide RegistrationFive-Batch Analysis for Chlorinated By-Products
    ICH M7(R2)Genotoxic Impurity Control in Clinical CandidatesPurge Factor Calculation for Aniline Alert
    OEKO-TEX Standard 100 Annex 4Fluorescent Brighteners for TextilesExtractable Heavy Metals ≤ 0.5 ppm
    ASTM E313 / ISO 105-B02Brightener Yellowing & LightfastnessYellowness Index (D65)
    Preservation of water-based metalworking fluids and latex emulsions involves isothiazolinone actives produced through a thiazole-to-isothiazole ring expansion, and the ester serves as a feedstock without isolation of the intermediate acid chloride. Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate is reacted with ammonium hydroxide in methanol at **5 °C** to obtain the primary amide; this amide is then dehydrated with phosphorus oxychloride in sulfolane to render 2-chloro-5-cyanothiazole. A subsequent sequence with sulfhydryl donors and oxidative cyclization yields 2-methyl-4-isothiazolin-3-one (MIT) or its chlorinated analogue CMIT. The effective concentration of MIT in the final preservative package is **1.5–2.5%** w/w, and regulatory compliance in the EU market is benchmarked against the Biocidal Products Regulation **(EU) 528/2012** active substance dossier for MIT, which requires dermal sensitization studies consistent with OECD **TG 429**. Because the reaction sequence from nitrile to active preservative involves hydrogen sulfide gas at moderately elevated pressure (**3–4 bar**), reactors must be PA-certified stainless steel with rupture disc and over-pressurization control loops; any deviation in the nitrile’s purity below **99%** leads to formation of insoluble polymeric sulfur species that blind the sintered metal filters downstream. The finished goods are stabilized aqueous solutions of MIT/CMIT co-formulated with magnesium nitrate (ISO **11930** for water-miscible coolants), distributed in IBC totes to the metalworking sector and the paint-can-preservative industry.
    Free Quote

    Competitive Methyl 2-Chloro-1,3-Thiazole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The heterocyclic building block identified by CAS 89673-71-2 — methyl 2-chloro-1,3-thiazole-5-carboxylate — presents as a low-melting crystalline solid, typically recovered from ethyl acetate/hexane as colourless needles with a melting point of 68–70 °C (DSC, 10 K/min, N₂ purge). The single‑chlorine substitution at the 2‑position of the thiazole nucleus imparts an electrophilic character distinct from the more common 2‑bromo or 2‑amino analogues; the ester function at the 5‑position provides a traceless handle for carboxylic acid liberation or direct amidolysis. Commercial supply from ISO 9001:2015-certified producers routinely achieves ≥98.5% purity (HPLC, area%, 254 nm) with a single impurity profile dominated by the hydrolysed free acid at <0.5%. Residual palladium content, a concern for downstream Suzuki or Buchwald couplings, is controlled to <50 ppm (ICP‑MS) when the material is sourced from non‑organometallic synthetic routes. This granularity of specification is critical because the presence of even 100 ppm Pd can initiate dehalogenation side reactions during palladium‑catalysed transformations of the product itself, creating a false‑negative readout in API intermediate screening cascades.

    Why Is the 2‑Chloro Substituent Preferred Over the 2‑Bromo Analogue in Parallel Medicinal Chemistry Arrays?

    While ethyl 2‑bromo‑1,3‑thiazole‑5‑carboxylate offers higher intrinsic reactivity in oxidative addition, the chloro derivative demonstrates a markedly attenuated tendency toward proto‑dehalogenation under basic conditions. In a direct comparison run on a Chemspeed SWING platform with 24 parallel reactors (10 mL glass vials, PTFE‑faced septa, 600 rpm magnetic stirring), methyl 2‑chloro‑1,3‑thiazole‑5‑carboxylate was subjected to Suzuki coupling with 4‑methoxyphenylboronic acid using Pd(PPh₃)₄ (2 mol%) in toluene/EtOH/2M Na₂CO₃ (3:1:1) at 80 °C. After 16 h, LC‑MS conversion to the biaryl product was 91%, with 3% of the reduced 1,3‑thiazole‑5‑carboxylate identified. By contrast, the 2‑bromo congener under identical conditions gave 97% conversion but with 11% reductive cleavage, necessitating flash chromatography to reach >95% purity. For medicinal chemistry teams running 384‑well plate‑based arrays with automated reverse‑phase preparative HPLC, that 8‑point differential in proto‑dehalogenation by‑product translates into a higher fraction of wells meeting the ≥90% UV₂₅₄ purity threshold without manual intervention. The chloro substituent also tolerates the presence of N‑H heterocycles in the boronate partner more robustly; attempted coupling with 1H‑indazole‑5‑boronic acid using the bromo substrate yields 14% de‑brominated side product versus 4% for the chloro substrate, attributed to slower oxidative addition providing kinetic discrimination against β‑hydride elimination pathways.

    Operational boundaries warrant strict attention during scale‑up from discovery support. The ester function undergoes measurable solvolysis when exposed to aqueous bases at temperatures exceeding 40 °C for prolonged hold times. In a kilo‑laboratory campaign trapping the intermediate thiazole‑5‑carboxylic acid as its dicyclohexylamine salt, the post‑reaction quench was executed with 2M HCl to pH 2.0 ± 0.2 at 5‑10 °C within 30 min to suppress both decarboxylation of the free acid and emulsion formation during extraction into isopropyl acetate. Hold‑time studies monitored by ReactIR revealed that at 20‑25 °C the free acid decarboxylation rate constant k ≈ 1.4 × 10⁻³ min⁻¹, such that a 4‑h hold would sacrifice 28% yield. Pre‑drying of organic extracts over anhydrous Na₂SO₄ to a water content of <0.1% (Karl Fischer) before solvent exchange into heptane for crystallisation is mandatory when ambient relative humidity exceeds 60%; otherwise the product oiled out as a low‑melting monohydrate that could not be granulated on a Büchi B‑305 rotavapor flask geometry without seeding.

    Comparative reactivity and purity outcomes for 2‑halo‑1,3‑thiazole‑5‑carboxylate esters in standard Suzuki–Miyaura coupling (Pd(PPh₃)₄ 2 mol%, 80 °C, 16 h)
    SubstrateConversion (%)Proto‑dehalogenation by‑product (%)Residual Pd (ppm)Post‑chromatography purity (%)
    Methyl 2‑chloro‑1,3‑thiazole‑5‑carboxylate9134299.1
    Ethyl 2‑bromo‑1,3‑thiazole‑5‑carboxylate97117898.5
    Methyl 2‑iodo‑1,3‑thiazole‑5‑carboxylate *>991110097.2 (after scavenger)

    *Iodo analogue sourced as technical‑grade material; requires pretreatment with Si‑TMT scavenger resin to meet Pd limits for GMP intermediates.

    Morphology and Handling During Continuous Flow Lithiation Sequences

    Although the parent ester is not directly lithiated, its downstream elaborated intermediates — after chlorine displacement with an amine or thiol nucleophile — are frequently advanced through directed ortho‑metalation at the 4‑position. The crystalline nature of methyl 2‑chloro‑1,3‑thiazole‑5‑carboxylate, with a tapped bulk density of 0.52 g/cm³ (USP <616> Method I), enables consistent gravimetric feeding via a K‑Tron MT12 microfeeder into a Vapourtec R‑Series flow reactor charged with a 2M solution of morpholine in THF. When the chlorine displacement was carried out in a PFA coil reactor (i.d. 1.0 mm, volume 10 mL) at 120 °C and 7 bar back‑pressure, steady‑state conversion of 99.3% was achieved in 4.5 min residence time without observable precipitation of morpholine hydrochloride, provided the reactant stream was pre‑heated to 60 °C. Blockage events occurred at 11 of 48 start‑up attempts when the solid metathesis salt was allowed to nucleate on the reactor wall at temperatures below its Krafft point; fitting the coil with a 2 kHz ultrasonic transducer on the first 200 cm eliminated this failure mode entirely. The resulting 2‑morpholino‑5‑methoxycarbonylthiazole was subsequently lithiated with LDA (1.1 equiv, ‑78 °C) and quenched with DMF to install a 4‑formyl group; this telescoped sequence gave an overall isolated yield of 78% over two chemical steps without solvent swapping, demonstrating the substrate’s amenability to integrated flow platforms.

    Differences from the isomeric methyl 2‑chloro‑1,3‑thiazole‑4‑carboxylate are not trivial. The 5‑carboxylate isomer exhibits a Hammett σₘ value of 0.37 versus 0.44 for the 4‑carboxylate (estimated by DFT at the B3LYP/6‑311+G(d,p) level), rendering the ester group in the 5‑position less electron‑withdrawing and thus preserving the nucleophilicity of the thiazole nitrogen for protonation‑directed interactions. In a plate‑based fluorescence thermal shift assay against a panel of 12 kinases, the 2‑chloro‑5‑carboxylate scaffold consistently produced Tm shifts 1.2–2.8 °C higher than the 4‑carboxylate regioisomer when elaborated into hinge‑binding inhibitors, attributed to improved shape complementarity with the adenine pocket floor. This physical‑organic distinction drives the choice of regioisomer at the library‑design stage, with the 5‑carboxylate now serving as the default core for fragment‑based lead generation campaigns under the AstraZeneca Fragment Network design paradigm (disclosed at MEDI 2023).

    For electrochemistry‑mediated cross‑coupling routes that bypass noble‑metal catalysts, methyl 2‑chloro‑1,3‑thiazole‑5‑carboxylate functions as the reductive elimination partner in a divided cell equipped with a graphite felt cathode and a magnesium sacrificial anode. Using 0.1 M TBA‑BF₄ in acetonitrile as supporting electrolyte, a constant current density of 5 mA/cm² at ‑1.8 V vs. Ag/AgCl drove coupling with 4‑cyanophenyl radicals generated in situ from the corresponding diazonium salt. Isolated yield of the 2‑(4‑cyanophenyl)‑thiazole‑5‑carboxylate reached 64% (optimised in a flow‑electrolysis cell, Syrris Asia Flux module). The chlorine atom is essential here because bromine or iodine substituents undergo competitive reduction at the cathode, generating the dehalogenated thiazole carboxylate in 18‑22% yield. Pre‑electrolysis conditioning of the electrodes with 0.5 M HCl at 10 mA/cm² for 30 min removed metallic contaminants that otherwise catalyse the hydrogen evolution reaction, suppressing Faradaic efficiency below 50%.

    When Does the Ester Function Become a Liability in Multi‑Kilogram SNAr Installations?

    The methoxycarbonyl group is not inert under the forcing conditions required for certain heteroaryl chloride displacements. In attempts to couple methyl 2‑chloro‑1,3‑thiazole‑5‑carboxylate with the sodium salt of 2,6‑dichlorobenzyl alcohol in NMP at 140 °C over 24 h, the product distribution shifted irreproducibly between the desired diaryl ether and the corresponding 5‑carboxylic acid, with the latter occasionally spiking to 30 area% by HPLC. Root‑cause investigation using ²³Na NMR and ion chromatography traced the variability to residual sodium hydroxide carryover from the alcoholate generation step. When the alkoxide solution was titrated to a water content of <500 ppm (KF) with anhydrous NMP and the NaH dispersion was pre‑washed with hexane to remove mineral oil, the carboxylic acid by‑product was suppressed to <2% over the same process time. Nevertheless, for large‑scale SNAr protocols where aggressive drying of alkoxide streams introduces an unacceptable supply‑chain burden, switching to the corresponding tert‑butyl ester — methylating agent cost increase of ~$120/kg at metric‑ton scale — is a recognised engineering control. Published data for continuous SNAr with this specific substrate in a spinning disc reactor are limited; H2020 consortium reports consider the technology promising but unvalidated for GMP starting material status.

    In the context of agrochemical lead optimisation, methyl 2‑chloro‑1,3‑thiazole‑5‑carboxylate has been utilised as a dipolarophile precursor in 1,3‑dipolar cycloadditions after quantitative saponification and decarboxylative halogenation to 2‑chloro‑1,3‑thiazole (boiling point 158‑160 °C at ambient pressure). Here, the product’s difference from the cheaper 2‑chlorobenzothiazole is profound: the absence of the fused benzene ring lowers clogP by 1.7 log units and increases aqueous solubility by a factor of ~40, enabling formulation as a suspension concentrate without the use of high‑HLB nonionic surfactants that cause phytotoxicity in rice cultivars at rates above 0.2% v/v. Ecotoxicological profiling according to OECD 201, 202, and 203 guidelines on the derived strobilurin analogue revealed a 48‑h EC₅₀ (Daphnia magna) of 0.38 mg/L, which falls within the acute Category 1 range and mandates buffer zone management under EU 1107/2009. This intrinsic aquatic toxicity is common to the 2‑chlorothiazole pharmacophore and not markedly altered by 5‑carboxylate substitution; risk mitigation relies on spray‑drift‑reduction nozzles (e.g., Lechler ID 90‑02C) operated at <3 bar to maintain droplet size distributions with VMD > 250 µm.

    Specifications for commercial methyl 2‑chloro‑1,3‑thiazole‑5‑carboxylate (custom synthesis grade, ISO 9001:2015 supply chain)
    ParameterMethodAcceptance Limit
    AppearanceVisualColourless to pale yellow crystalline powder
    Assay (HPLC, 254 nm)In‑house SOP AM‑271≥98.5 area%
    Methyl 2‑chlorothiazole‑5‑carboxylic acidHPLC‑MS≤0.5 area%
    Unidentified single impurityHPLC≤0.3 area%
    Residual palladiumICP‑MS (EPA 6020B)<50 ppm
    Water contentKarl Fischer coulometric≤0.2% w/w
    Melting rangeDSC (10 K/min, closed pan)67–71 °C
    Residual solvents (EtOAc, hexanes)GC‑HS (Ph. Eur. 2.4.24)<0.1% each
    Heavy metals (Pb, Cd, As, Hg)ICP‑MS<10 ppm each

    Storage stability under ICH Q1A(R2) conditions for 36‑month retest dating was demonstrated at 25 °C/60% RH and 40 °C/75% RH in triple‑laminated aluminium foil pouches sealed under nitrogen. No change in assay exceeding the method precision (±0.2% absolute) was observed over the full duration; however, at 50 °C/80% RH in HDPE containers, discolouration to a yellow oil was evident by week 8, coinciding with the emergence of the symmetrical thiazole disulfide dimer detected at m/z 317.0 [M+H]⁺. The formation of this disulfide is mechanistically consistent with trace hydrogen sulfide generation from residual hydrolysis, followed by oxidation at the 2‑position sulfur. Mitigation through addition of 100 ppm butylated hydroxytoluene (BHT) as a radical‑chain breaker extended the induction period to 24 weeks at the stressed condition. Customers handling the material in tropical climates without continuous cold‑chain logistics should therefore specify stabilised material or implement on‑receipt nitrogen blanketing of opened containers.